Marshall Wace’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $327K | Buy |
+42,355
| New | +$327K | ﹤0.01% | 2170 |
|
|
2025
Q1 | – | Sell |
-24,958
| Closed | -$332K | – | 2471 |
|
|
2024
Q4 | $332K | Buy |
+24,958
| New | +$332K | ﹤0.01% | 2053 |
|
|
2024
Q2 | – | Sell |
-1,690
| Closed | -$29.1K | – | 2291 |
|
|
2024
Q1 | $29.1K | Sell |
1,690
-10,010
| -86% | -$173K | ﹤0.01% | 2069 |
|
|
2023
Q4 | $149K | Buy |
+11,700
| New | +$149K | ﹤0.01% | 1702 |
|
|
2023
Q3 | – | Sell |
-2,487
| Closed | -$100K | – | 1837 |
|
|
2023
Q2 | $100K | Buy |
+2,487
| New | +$100K | ﹤0.01% | 1880 |
|
|
2022
Q4 | – | Sell |
-3,064
| Closed | -$290K | – | 2317 |
|
|
2022
Q3 | $290K | Buy |
+3,064
| New | +$290K | ﹤0.01% | 2242 |
|
|
2021
Q2 | – | Sell |
-3,051
| Closed | -$1.1M | – | 2092 |
|
|
2021
Q1 | $1.1M | Sell |
3,051
-22,259
| -88% | -$8M | 0.01% | 1362 |
|
|
2020
Q4 | $12.4M | Buy |
25,310
+14,323
| +130% | +$7.03M | 0.07% | 259 |
|
|
2020
Q3 | $3.56M | Sell |
10,987
-19,892
| -64% | -$6.45M | 0.02% | 597 |
|
|
2020
Q2 | $11.2M | Buy |
+30,879
| New | +$11.2M | 0.08% | 242 |
|
|
2019
Q2 | – | Sell |
-286
| Closed | -$284K | – | 1304 |
|
|
2019
Q1 | $284K | Buy |
+286
| New | +$284K | ﹤0.01% | 1261 |
|